Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
10/2010
10/21/2010US20100266717 Chemical and biological agents for the control of molluscs
10/21/2010CA2758895A1 Derivatives of n-acyl-n'-phenylpiperazine useful (inter alia) for the prophylaxis or treatment of diabetes
10/21/2010CA2758484A1 Anti-viral compounds
10/21/2010CA2758367A1 Derivatives of n-[(7-aza-bicyclo[2.2.1]hept-1-yl)-aryl-methyl]-benzamide, preparation thereof, and therapeutic use thereof
10/20/2010EP2240492A1 Process for the preparation of asenapine and intermediate products used in said process
10/20/2010EP2240442A2 Preparation process useful in synthesis of atorvastatin
10/20/2010EP2240441A1 Process for the preparation of 6-substituted-1-(2h)-isoquinolinones
10/20/2010EP1984331B1 Pyrrolidine derivatives as erk inhibitors
10/20/2010EP1899320B1 Substituted pyrr0lidin-2-0nes , piperidin-2-0nes and isothiazolidine-1, 1-dioxides, their use as kv1 .5 potassium channel blockers and pharmaceutical preparations comprising them
10/20/2010EP1789377B1 Alternative synthesis of renin inhibitors and intermediates thereof
10/20/2010EP1780197B1 5-substituted-2-phenylamino benzamides as mek inhibitors
10/20/2010EP1613762B1 Process for producing enantiopure beta-amino acid derivatives, and enantiopure beta-amino acid derivatives
10/20/2010EP0959075B1 Heteroarylpiperidines and piperazines and their use as antipsychotics and analgetics
10/20/2010CN101868455A Therapeutic substituted lactams
10/20/2010CN101863821A Method for preparing chiral hydrazine by taking chiral proline ester as raw material
10/20/2010CN101863820A 3-acylpyrrolidine-2,4-diketone semicarbazone compound, preparation method thereof and application
10/20/2010CN101863819A Method for preparing magnesium L-pyroglutamate
10/20/2010CN101863818A Method for preparing DL-proline
10/20/2010CN101863817A Preparation method of (2S, 4R)-4-aminopyrroline-1,2-dicarboxylic acid-1-tertiary butyl ester-2-methyl ester hydrochloride
10/20/2010CN101863816A Method for separating hydroxyproline by using chitosan resin
10/20/2010CN101863815A Synthesis method of cis 3-phenyl substituted s-proline derivative
10/20/2010CN101863814A Method for refining stachydrine from motherwort
10/19/2010US7816560 N-nonyl-1,5,6-trideoxy-1,5-imino-D-galactitol; N-(7-oxa-nonyl)-1,5,6-trideoxy-1,5-imino-D-galactito; viricide; for treating hepatitis
10/19/2010US7816534 N-[3-(4-chlorophenyl)-2-(3-pyridyl)-1-methylpropyl]-2-(5-trifluoromethyl-2-pyridyloxy)-2-methylpropanamide; obesity; antipsychotic agents; synergistic; cannabinoid receptor antagonists
10/19/2010US7816408 (N-{5-[(4-chlorophenyl)thio]pentyl}-N-[(1R)-1-(1-naphthyl)ethyl]amine); mimics/blocks effect of extracellular calcium in parathyroid cells, juxtaglomerular/proximal tubule kidney cells, parafollicular thyroid cells, bone osteoclasts, keratinocytes or placental trophoblasts; hyperparathyroidism
10/19/2010US7816398 Fatty alcohol drug conjugates
10/19/2010US7816395 Pyrrolidinone anilines as progesterone receptor modulators
10/19/2010US7816389 Organic compounds
10/19/2010US7816375 Ligands for monoamine receptors and transporters, and methods of use thereof
10/19/2010US7816363 Inhibitors of histone deacetylase
10/14/2010WO2010118055A1 Inhibitors of cognitive decline
10/14/2010WO2010117619A2 Amine-terminated telechelic polymers and precursors thereto and methods for their preparation
10/14/2010WO2010117040A1 Five-membered heterocyclic compound
10/14/2010WO2010115937A1 Process for preparing pyrrolidinium salts
10/14/2010WO2010115688A1 Anthelmintic agents and their use
10/14/2010WO2010075086A3 Pyrrolidinone inhibitors of pde-4
10/14/2010US20100261914 Iap binding compounds
10/14/2010US20100261863 Multibranched polyoxyalkylene compound and producing method thereof
10/14/2010US20100261761 Novel Sulfonylpyrroles
10/14/2010US20100261754 Novel rar receptor agonist ligands and use thereof in human medicine and cosmetics
10/14/2010US20100261721 Novel Sulphonylpyrroles
10/14/2010US20100261245 Long acting formulation of biopharmaceutical
10/14/2010US20100260851 Novel Polymorph of Atorvastatin Calcium and Use Thereof for the Preparation of Amorphous Atorvastatin Calcium
10/14/2010CA2758100A1 Process for preparing pyrrolidinium salts
10/14/2010CA2757267A1 Amine-terminated telechelic polymers and precursors thereto and methods for their preparation
10/14/2010CA2755669A1 Anthelmintic agents and their use
10/13/2010EP2239263A1 Cyclic compound, its metal complex, and modified metal complex
10/13/2010EP2239253A1 Novel phenylpyrrole derivative
10/13/2010EP2238101A2 Difluorobiphenylamide derivatives for the treatment of ocular hypertension
10/13/2010CN1939922B 5H-thiophene [3,4-C] pyrrole-4,6-diketone derivative for inhibiting cell release tumor necrosis factor
10/13/2010CN1916760B Acid-producing agent, sulfonic acid, sulfonic acid derivative and radiation-sensitive resin composition
10/13/2010CN101861302A Pyrrolidine aryl-ether as NK3 receptor antagonists
10/13/2010CN101861174A Derivatized tertiary amines and uses thereof
10/13/2010CN101857535A Processes for the synthesis of gamma nitrocarbonyl and gamma dicarbonyl compounds and their pyrrole derivatives
10/13/2010CN101139314B Method for preparing (3R,4R)-3,4-dihydroxy pyrrolidine-2-ketone
10/12/2010US7812180 such as 3-ferrocenylpropyl 2-(3-pyrrolyl)ethyl phosphate diester; for detecting nucleotides, antibodies in biological samples
10/12/2010US7812179 Preparing 5-[2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol-1-yl]-3hydroxyl-1-pentanoic acid 7 by reacting aldehyde with 2-hydroxy-1,2,2-triphenylethyl acetate and a chelating cosolvent; hydrolysis; carboxylation by reaction with base; salt formation, purification
10/12/2010US7812178 such as (R)-3-(3-hydroxypyrrolidin-1-yl)-N-methyl-N-methoxypropanamide; poly(ADP-ribose)polymerase inhibitors
10/12/2010US7812041 such as 2-Morpholin-4-yl-thiazole-4-carboxylic acid (5,6-dimethyl-1H-benzoimidazol-2-yl)-amide, used for the treatment of dementia, amyotrophic lateral sclerosis, stroke, epilepsy, multiple sclerosis, myasthenia gravis, Huntington's, Alzheimer's, Parkinson's, Meniere's and Creutzfeld-Jacob Disease
10/12/2010US7812040 Histamine-3 receptor antagonists
10/12/2010US7812038 such as vascular cell adhesion molecules and fibronectins, administered for the treatment of asthma, multiple sclerosis or inflammatory bowel diseases in mammals; (3S)-3-{[({1-[(2-chlorophenyl)methyl]-4-hydroxy-2-oxo-1,2-dihydro-3quinolinyl}amino)carbonyl]amino}-3-(4-methylphenyl)propanoic acid
10/12/2010US7812033 Method for increasing the activity of acid-β-galactosidase
10/12/2010US7812021 {(3RS,4SR)-3-(3,4-dichloro-phenyl)-4-[(RS)-1-(4-trifluoromethyl-phenoxy)-ethyl]-pyrrolidin-1-yl}-(4-methanesulfonyl-piperazin-1-yl)-methanone, for the treatment of depression, pain, psychosis, Parkinson's disease, schizophrenia, anxiety and attention deficit hyperactivity disorder
10/12/2010CA2407149C Melanin-concentrating hormone antagonist
10/07/2010WO2010113860A1 Biphenyl-cyclic amine compound
10/07/2010WO2010074996A3 A post-treated additive composition and method of making the same
10/07/2010WO2010019435A3 Solid states of atorvastatin potassium
10/07/2010US20100256394 Method for the preparation of lasofoxifene
10/07/2010US20100256391 Processes for the synthesis of gamma nitrocarbonyl and gamma dicarbonyl compounds and their pyrrole derivatives
10/07/2010US20100256382 Tri-aryl compounds and compositions comprising the same
10/07/2010US20100256367 Pharmaceutical Composition For Preventing and Treating Metabolic Bone Diseases Containing Alpha-Arylmethoxyactylate Derivatives
10/07/2010US20100256329 Stereoselective alternating copolymerization of epoxide with carbon dioxide
10/07/2010US20100256216 2-acylaminopropoanol-type glucosylceramide synthase inhibitors
10/07/2010US20100256213 Tosylate Salt Of Trans-N-Isobutyl-3-Fluoro-3- [3-Fluoro-4-(Pyrrolidin-1-YL-Methyl)-Phenyl] Cyclobut Anecarboxamide
10/07/2010US20100256201 Cell differentiation inducer
10/07/2010US20100256156 Heterocyclic compound
10/07/2010US20100256144 Kallikrein 7 modulators
10/07/2010US20100256130 Morpholinyl and pyrrolidinyl analogs
10/07/2010US20100256129 Selective androgen receptor modulators (sarms) and uses thereof
10/07/2010US20100256115 Inhibitors of iap
10/07/2010US20100256114 Amido Compounds And Their Use As Pharmaceuticals
10/07/2010US20100256028 Functional fluids for internal combustion engines
10/07/2010US20100252433 Novel optical labeling molecules for proteomics and other biological analyses
10/06/2010EP2236497A1 Colored curable composition, method for producing color filter, color filter, solid-state image pickup device, and liquid crystal display device
10/06/2010EP2236496A1 Optically active 3-aminopyrrolidine salt, process for production thereof, and method for optical resolution of 3-aminopyrrolidine
10/06/2010EP2236495A1 New salts for adding angiotensin conversion enzyme inhibitors to NO-donor acids, method of preparing same and pharmaceutical compositions containing them
10/06/2010EP2235014A2 Bicyclic derivatives of azabicyclic carboxamides, preparation thereof and therapeutic use thereof
10/06/2010EP2234997A1 Process for the preparation of pyrido ý2,1-a¨isoquinoline derivatives
10/06/2010EP2234967A1 Compounds from mycelium of antrodia cinnamomea and use thereof
10/06/2010CN1942186B Pyrrolidine compounds
10/06/2010CN101853963A Over-charge prevention lithium ion battery electrolyte and lithium ion battery prepared by using same
10/06/2010CN101851244A Substituted phenyl keto enols as pesticides and herbicides
10/06/2010CN101851211A Novel piperazinoamide compound
10/06/2010CN101851188A Method and device for extracting Alpha-pyrrolidone and N-vinyl pyrrolidine by integrating side rectification and extractive distillation
10/06/2010CN101851143A Method for alkylating amine and amino acid
10/06/2010CN101849953A Inflammatory cytokine release inhibitor
10/06/2010CN101062928B Process for preparing 2-pyrrolidinyl-1h-pyrrolo[3,2-d]pyrimidine inhibitors of nucleoside metabolism
10/05/2010US7807858 Process for production of fluoro derivative
10/05/2010US7807846 Method for producing succinimide compound
10/05/2010US7807709 3,4-substituted pyrrolidines; renin inhibitors; cardiovascular disorders, kidney disorders, neurodegenerative diorders and other diseases related to renin; e.g. N-((3S*,4S*)-4-{[Cyclopropyl-(4-methyl-pentanoyl)-amino]-methyl}-pyrrolidin-3-ylmethyl)-N-isopropyl-4-methoxy-3-(3-methoxy-propoxy)-benzamide
1 ... 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 ... 404